According to Stratistics MRC, the Global Medical Foods Market is accounted for $20.15 billion in 2020 and is expected to reach $35.14 billion by 2028 growing at a CAGR of 7.2% during the forecast period. Factors such as increasing geriatric population, rising adoption of healthy alternatives, and high expenditure in healthcare sector by governments in developed economies are driving the market growth. However, lack of awareness related to proper use of medical foods is hampering the growth of the market.
Request for a Free Sample Copy of Report at www.strategymrc.com/report/medical-foods-market/request-sample
Based on the route of administration, the oral segment is going to have a lucrative growth during the forecast period which can be attributed to the high commercial viability of orally administered products as well as its ease of consumption. By geography, North America is expected to grow at a faster rate during the forecast period owing to the increasing unhealthy lifestyle among individuals in the region.
Some of the key players profiled in the Medical Foods Market include Reckitt Benckiser Group plc, Abbott Laboratories, Danone S.A., Nestlé S.A., Mead Johnson, BioMarin Pharmaceutical, Ajinomoto Cambrooke Inc, Fresenius SE & Co. KGaA, Targeted Medical Pharma Inc, Accera Inc, Alfasigma S.p.A., Metagenics Inc, Meiji Holdings and Co Ltd, Cerecin Inc, and Primus Pharmaceuticals Inc.
Routes of Administration Covered:
• Enteral
• Oral
Products Covered:
• Oral Rehydration Products
• Nutritionally Complete Formulas
• Nutritionally Incomplete Formulas
Nutritional Ingredients Covered:
• Proteins
• Vitamins and Minerals
• Isoflavones
• Omega-3
• Phytosterols
Forms Covered:
• Powder
• Liquid
• Tablets & Capsules
• Gels
• Bars
• Other Forms
Packagings Covered:
• Packets
• Bottle
• Can
• Jar
Age Groups Covered:
• Adults
• Adolescent
• Weaning
• Infants
Applications Covered:
• Alzheimer’s Disease
• Cancer (Chemotherapy-Induced Diarrhea)
• Attention Deficit Hyperactivity Disorder (ADHD)
• Sleep Management
• Neuro-Degenerative Disorders
• Maple Syrup Urine Disease (MSUD)
• Diabetes (Diabetic Neuropathy)
• Depression
• Chronic Conditions
• Obesity and Hypertension
• Urea Cycle Disorders
• Inborn Errors of Metabolism
• Pathogen Related Infections
• Minimal Hepatic Encephalopathy
• Neurological & Psychological Disorders
• Nutritional Deficiency
• Ophthalmology
• Orphan Diseases
• Homocystinuria
• Organic Acidurias
• Pain Management
• Gastrointestinal Disorders
• Methylmalonic Acidemia
• Isovaleric Acidemia
• Propionic Acidemia
• Tyrosinemia Types I And II
Sales Channels Covered:
• Retail Sales
• Online Sales
• Institutional Sales (Hospital Pharmacies)
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
If Any Query? Ask Our Industry Expert at www.strategymrc.com/report/medical-foods-market/request-customization
Explore the list of attractive markets during this time of Pandemic @ www.strategymrc.com/covid-19-impact-reports
About Us:
StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.
Contact Us:
Stratistics Market Research Consulting
Phone: +1-301-202-5929
Email: info@strategymrc.com
Website: www.strategymrc.com/
Twitter:twitter.com/StratisticsMRC
LinkedIn: www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile